26D 12H 23M 03S
15-16 août
Programme de sommet
Façonner une communauté de la maladie du sang de cellules falciformes plus saine demain, grâce à des actions aujourd'hui
26D 12H 23M 03S
15-16 août
Programme de sommet
Façonner une communauté de la maladie du sang de cellules falciformes plus saine demain, grâce à des actions aujourd'hui
26D 12H 23M 03S
15-16 août
Programme de sommet
Façonner une communauté de la maladie du sang de cellules falciformes plus saine demain, grâce à des actions aujourd'hui
25 sessions available
Friday August 21st
Arrival / Registration & Breakfast
Official Opening & Welcome
Modernizing SCD Care – Re-imagining the Treatment Model from Crisis Intervention to Health Maintenance
Keynote Address (with Q&A)
Hydroxyurea, Transfusion, and Beyond: Treatment Decisions in Sickle Cell Disease
Plenary session
Morning Break
Lunch
Renal and Pulmonary Hypertension – Complications in Sickle Cell Disease
Patient Track – Concurrent Session A (with Q&A)
Innovations in Sickle Cell Disease: Translating Gene and Cell Therapies into Global Practice
Provider Track – Concurrent Session A (with Q&A)
The Role of Lived Experience in Shaping Inclusive Healthcare Policies
Patient Track – Concurrent Session B (with Q&A)
Apheresis – Optimal Exchange Transfusion Practices in Sickle Cell Disease
Provider Track – Concurrent Session B (with Q&A)
Break
Research Abstract – Oral Presentations
Research Session
Saturday August 22nd
Breakfast
Opening and Welcome
From Innovation to Impact: Centering Lived Experience to Transform the Sickle Cell Care Journey
Keynote Address (with Q&A)
Understanding Inheritance: Sickle Cell Trait and Its Impact on Future Generations
Plenary (with Q&A)
Break
Mental Health, Psychosocial Needs, and Dedicated Resources and Supports
Patient Track – Concurrent Session A (with Q&A)
Canadian Guidelines & Protocols in Sickle Cell Disease to Support Equitable Access to Care
Provider Track – Concurrent Session A (with Q&A)
Break
Lunch
Overcoming Challenges in Transitioning from Pediatric to Adult Care
Patient Track – Concurrent Session B (with Q&A)
Inpatient Sickle Cell Disease Management – What Clinicians Need to Know?
Provider Track – Concurrent Session B (with Q&A)
Precision Medicine in SCD: Integrating Genomics, Biomarkers, and Personalized Care
Plenary Panel Talk (with Q&A)
Closing Remarks

Liens rapides
Contacter
Addresse : 330-5109 Steeles Ave W.
North York, ON , M9L 2Y8
Téléphone : GTA : 416-745-4267
Courriel : info@sicklecellanemia.ca
© SCAGO - Tous droits réservés - Avis de non-responsabilité - Numéro d'enregistrement de bienfaisance #: 83332 0872 RR 0001
Liens rapides
Contacter
Adresse : 330-5109 Steeles Ave W.
North York, ON M9L 2Y8
Téléphone : 416-745-4267
Courriel : info@sicklecellanemia.ca
© SCAGO - Tous droits réservés - Avis de non-responsabilité - Numéro d'enregistrement de bienfaisance #: 83332 0872 RR 0001
Liens rapides
Contacter
Adresse : 330-5109 Steeles Ave W.
North York, ON M9L 2Y8
Téléphone : 416-745-4267
Courriel : info@sicklecellanemia.ca
© SCAGO - Tous droits réservés - Avis de non-responsabilité - Numéro d'enregistrement de bienfaisance #: 83332 0872 RR 0001




